Sugi Predict

Sugi Predict / Targets / TMEM161A

TMEM161A

Transmembrane protein 161A · Q9NX61 · TMEM161A on Sugi Atlas →

0 patent compounds predicted against TMEM161A, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TMEM161A by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy PHASE1/PHASE2RECRUITING
Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy PHASE2RECRUITING
A Multicenter Study of NAP (AL-108) in Schizophrenia PHASE2COMPLETED
Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype EARLY_PHASE1COMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Brain P-gp and Inflammation in People With Epilepsy nanCOMPLETED
Phenotypic and Genotypic Studies in Congenital and Early Onset Ataxias nanCOMPLETED
PCD New Gene Discovery nanCOMPLETED
Seven Year Update of Macular Degeneration Patients nanCOMPLETED
Personalized Breast Cancer Screening nanACTIVE_NOT_RECRUITING
Markers and Mechanisms of Macrovascular Disease in IDDM nanCOMPLETED
Primary Ciliary Dyskinesia in Adult Bronchiectasis nanNOT_YET_RECRUITING
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts nanCOMPLETED
Genetic Study of Age-Related Macular Degeneration nanCOMPLETED
Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism nanCOMPLETED
Specificities of Atypical Non AutoImmune Diabetes (ANAID) in the French West Indies nanNOT_YET_RECRUITING
Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis nanCOMPLETED
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy nanCOMPLETED
Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer nanCOMPLETED
LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients nanACTIVE_NOT_RECRUITING
New Strategies of Genetic Study of Patients With Oculocutaneous Albinism nanCOMPLETED
Respiratory Registry for Lung Health: a Prospective, Observational Study on Adult Patients With Asthma or COPD nanUNKNOWN
Biomarkers of Risk of Parkinson Disease nanCOMPLETED
Genetic Study of Patients With Primary Ciliary Dyskinesia nanCOMPLETED
Study of Usher Syndromes, Type 1 and Type 2 nanCOMPLETED
Diagnosis of Primary Ciliary Dyskinesia nanCOMPLETED
Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer nanCOMPLETED
Biomarker Research in Inherited Movement Disorders nanRECRUITING
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a TMEM161A binder may also engage these)

ProteinNameSimilarity
Q8VCA6 — 0.999 Q8VCA6 →
Q6GMB1 — 0.997 Q6GMB1 →
Q28FG4 — 0.997 Q28FG4 →
Q7SY10 — 0.994 Q7SY10 →
Q0V947 — 0.990 Q0V947 →
Q8C2L6 — 0.989 Q8C2L6 →
Q8NDZ6 — 0.988 Q8NDZ6 →
STRA6 Receptor for retinol uptake STRA6 0.986 landscape →
Q5R7B4 — 0.984 Q5R7B4 →
A3KN25 — 0.983 A3KN25 →
Q6PH58 — 0.982 Q6PH58 →
Q6DF19 — 0.982 Q6DF19 →
Q9FKY5 — 0.981 Q9FKY5 →
Q6NRI4 — 0.981 Q6NRI4 →
PIGO GPI ethanolamine phosphate transferase 3, catalytic subunit 0.981 landscape →
Q5T197 — 0.980 Q5T197 →
Q9CRG1 — 0.980 Q9CRG1 →
Q3SZ36 — 0.980 Q3SZ36 →
F1RAX4 — 0.980 F1RAX4 →
Q4QR83 — 0.980 Q4QR83 →
Q9P055 — 0.980 Q9P055 →
Q8CE93 — 0.980 Q8CE93 →
P35212 — 0.979 P35212 →
O22757 — 0.979 O22757 →
Q9BVI4 — 0.979 Q9BVI4 →
Q8NFK1 — 0.979 Q8NFK1 →
Q0IHF1 — 0.979 Q0IHF1 →
O95377 — 0.979 O95377 →
Q3U1N2 — 0.979 Q3U1N2 →
O70491 — 0.979 O70491 →